Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa

International Journal of Eating Disorders

Volumn 46, Issue 6, 2013, Pages 626-629

  Conti, Elisa ^a   Tremolizzo, Lucio ^a   Bomba, Monica ^a   Uccellini, Orlando ^a   Rossi, Maria Sara ^a   Raggi, Maria Elisabetta ^b   Neri, Francesca ^a   Ferrarese, Carlo ^a   Nacinovich, Renata ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

anorexia nervosa; biomarker; depression; diazepam binding inhibitor; leptin

Indexed keywords

DIAZEPAM BINDING INHIBITOR; LEPTIN;

ADOLESCENT; ANOREXIA NERVOSA; ANXIETY; ARTICLE; BODY MASS; CHILDREN DEPRESSION INVENTORY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MOOD CHANGE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; STATE TRAIT ANXIETY INVENTORY;

EID: 84883165336     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.22129     Document Type: Article

References (22)

1. Tong J, D'Alessio D,. Eating disorders and gastrointestinal peptides. Curr Opin Endocrinol Diabetes Obes 2011; 18: 42-49.
2. Prince AC, Brooks SJ, Stahl D, Treasure J,. Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr 2009; 89: 755-765.
3. Stein D, Maayan R, Ram A, Loewenthal R, Achiron A, Modan-Moses D, et al. Circulatory neurosteroid levels in underweight female adolescent anorexia nervosa inpatients and following weight restoration. Eur Neuropsychopharmacol 2005; 15: 647-653.
4. Herzig KH, Schön I, Tatemoto K, Ohe Y, Li Y, Fölsch UR, et al. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc Natl Acad Sci USA 1996; 93: 7927-7932.
5. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Borowiec M,. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2000; 2: 99-103.
6. Ferrarese C, Appollonio I, Bianchi G, Frigo M, Marzorati C, Pecora N, et al. Benzodiazepine receptors and diazepam binding inhibitor: A possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 1993; 18: 3-22.
7. Guidotti A,. Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior. Neuropharmacology 1991; 30: 1425-1433.
8. van Broekhoven F, Verkes RJ,. Neurosteroids in depression: A review. Psychopharmacology (Berl) 2003; 165: 97-110.
9. Brichard SM, Delporte ML, Lambert M,. Adipocytokines in anorexia nervosa: A review focusing on leptin and adiponectin. Horm Metab Res 2003; 35: 337-342.
10. Bronsky J, Nedvidkova J, Krasnicanova H, Vesela M, Schmidtova J, Koutek J, et al. Changes of orexin A plasma levels in girls with anorexia nervosa during eight weeks of realimentation. Int J Eat Disord 2011; 44: 547-552.
11. Begni B, Tremolizzo L, Andreoni S, Contri M, Uccellini O, Neri F, et al. Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients. Neurosci Lett 2009; 462: 144-146.
12. Kennedy SH, Kaplan AS, Garfinkel PE, Rockert W, Toner B, Abbey SE,. Depression in anorexia nervosa and bulimia nervosa: Discriminating depressive symptoms and episodes. J Psychosom Res 1994; 38: 773-782.
13. Sala L, Mirabel-Sarron C, Gorwood P, Pham-Scottez A, Blanchet A, Rouillon F,. The level of associated depression and anxiety traits improves during weight regain in eating disorder patients. Eat Weight Disord 2011; 16: e280-e284.
14. Williams DL, Baskin DG, Schwartz MW,. Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1238-R1246.
15. Bovolin P, Schlichting J, Miyata M, Ferrarese C, Guidotti A, Alho H,. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul Pept 1990; 29: 267-281.
16. Venturini I, Zeneroli ML, Corsi L, Baraldi C, Ferrarese C, Pecora N, et al. Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma. Regul Pept 1998; 74: 31-34.
17. Bailer UF, Kaye WH,. A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Curr Drug Targets CNS Neurol Disord 2003; 2: 53-59.
18. Payeur R, Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Zealberg J,. CSF diazepam-binding inhibitor concentrations in panic disorder. Biol Psychiatry 1992; 32: 712-716.
19. Roy A,. Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls. Neuropharmacology 1991; 30: 1441-1444.
20. Hughes HK,. Comorbid depression and anxiety in childhood and adolescent anorexia nervosa: Prevalence and implications for outcome. Clin Psychol 2012; 16: 15-24.
21. Fennig S, Fennig S, Roe D,. Physical recovery in anorexia nervosa: Is this the sole purpose of a child and adolescent medical-psychiatric unit? Gen Hosp Psychiatry 2002; 24: 87-92.
22. Morley JE,. Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 2013; 16: 27-32.